These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1495020)

  • 61. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
    Mockenhaupt FP; Bedu-Addo G; Junge C; Hommerich L; Eggelte TA; Bienzle U
    Antimicrob Agents Chemother; 2007 Jan; 51(1):332-4. PubMed ID: 17088491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Some studies on the effects of dihydrofolate reductase inhibitors.
    Gitteridge WE; Trigg PI
    Trans R Soc Trop Med Hyg; 1970; 64(1):12. PubMed ID: 5442030
    [No Abstract]   [Full Text] [Related]  

  • 64. Plasmodium chabaudi: genetics of resistance to chloroquine.
    Padua RA
    Exp Parasitol; 1981 Dec; 52(3):419-26. PubMed ID: 6947894
    [No Abstract]   [Full Text] [Related]  

  • 65. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
    J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Properties of DNA from some malarial parasites.
    Gutteridge WE; Trigg PI; Williamson DH
    Parasitology; 1971 Apr; 62(2):209-19. PubMed ID: 4995420
    [No Abstract]   [Full Text] [Related]  

  • 67. Alteration in properties of thymidylate synthetase from pyrimethamine-resistant Plasmodium chabaudi.
    Ratanaphan A; Ruenwongsa P
    Int J Parasitol; 1986 Oct; 16(5):483-90. PubMed ID: 3781732
    [No Abstract]   [Full Text] [Related]  

  • 68. Comparison of the effects of methotrexate and pyrimethamine on L5178Y lymphoblasts in cell culture.
    Goldie JH; Furness ME; Price LA
    Eur J Cancer (1965); 1973 Oct; 9(10):709-15. PubMed ID: 4529729
    [No Abstract]   [Full Text] [Related]  

  • 69. Inhibitors of dihydrofolic acid reductase in the therapy of infectious diseases.
    Hitchings GH
    Bibl Nutr Dieta; 1966; 8():226-37. PubMed ID: 5331137
    [No Abstract]   [Full Text] [Related]  

  • 70. Differential binding to the hydrophobic bonding region of T2 phage induced, Escherichia coli B, and pigeon liver dihydrofolic reductases.
    Baker BR
    J Med Chem; 1967 Sep; 10(5):912-7. PubMed ID: 4860445
    [No Abstract]   [Full Text] [Related]  

  • 71. Persistence of pyrimethamine resistance in the exoerythrocytic stages of Plasmodium gallinaceum.
    Beaudoin RL; Strome CP; Huff CG
    Exp Parasitol; 1967 Apr; 20(2):156-9. PubMed ID: 6036478
    [No Abstract]   [Full Text] [Related]  

  • 72. Genetic studies on Plasmodium chabaudi: recombination between enzyme markers.
    Walliker D; Carter R; Sanderson A
    Parasitology; 1975 Feb; 70(1):19-24. PubMed ID: 1118185
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Point mutations may account for pyrimethamine resistance.
    Ash C
    Trends Pharmacol Sci; 1989 Aug; 10(8):303-4. PubMed ID: 2686125
    [No Abstract]   [Full Text] [Related]  

  • 74. Synthesis of site-directed chelating agents. I. Pteridine carboxaldehyde thiosemicarbazones.
    Hochman HI; Agrawal KC; Shansky CW; Sartorelli AC
    J Pharm Sci; 1973 Jan; 62(1):150-1. PubMed ID: 4682920
    [No Abstract]   [Full Text] [Related]  

  • 75. Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei.
    Ferone R
    J Biol Chem; 1970 Feb; 245(4):850-4. PubMed ID: 5418106
    [No Abstract]   [Full Text] [Related]  

  • 76. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 77. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studies of Plasmodium falciparum dihydrofolate-reductase thymidylate synthase: potential advantages.
    Inselburg J; Bzik DJ; Gu H; Li WB; Horii T
    Prog Clin Biol Res; 1989; 313():29-43. PubMed ID: 2675115
    [No Abstract]   [Full Text] [Related]  

  • 79. Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
    Wagner CR; Benkovic SJ
    J Med Chem; 1992 Jul; 35(15):2912-5. PubMed ID: 1495020
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.